Skip to main content
. Author manuscript; available in PMC: 2022 Mar 31.
Published in final edited form as: Am J Prev Med. 2015 Jul;49(1):112–123. doi: 10.1016/j.amepre.2015.03.004

Table 4.

Mean Sensitivity Analyses Results With 95% Uncertainty Intervals

Secondary scenario: Impact on BMI based on TEI studies Tertiary scenario: Impact on BMI based on beverage substitution Costs as 3% of annual tax revenue 50% Tax pass-through ratef 150% Tax pass-through ratef Lowest identified own-price elasticity
Total population reached (millions) 313 313 313 313 313 313
First-year intervention cost ($ millions) 51.0 (36.4; 65.5) 51.0 (36.4; 65.5) 375 (268; 422) 51.0 (36.4; 65.5) 51.0 (36.4; 65.5) 51.0 (36.4; 65.5)
Ten-year intervention cost ($ millions) 430 (307; 552) 430 (307; 552) 3,170 (2,250; 3,560) 430 (307; 552) 430 (307; 552) 430 (307; 552)

Short-term Outcomes

Mean per capita BMI unit reduction for adults >19 years of age 0.38 (0.18; 0.84) 0.35 (0.15; 0.83) 0.08 (0.03; 0.20) 0.04 (0.02; 0.10) 0.13 (0.05; 0.30) 0.05 (0.03; 0.07)
Mean per capita BMI unit reduction for youth 2-19 years of age 0.62 (0.30; 1.40) 0.27 (0.06; 0.73) 0.16 (0.06; 0.37) 0.08 (0.03; 0.19) 0.24 (0.09; 0.56) 0.09 (0.04; 0.14)
Total BMI units reduced (millions) 135 (66.1; 302) 102 (41.7; 250) 31.7 (12.7; 74.3) 15.8 (6.37; 37.2) 47.5 (19.1; 111) 18.0 (9.97; 26.0)
Cost per BMI unit reduceda ($) 0.74 (0.30; 1.64) 0.98 (0.37; 2.55) 23.3 (7.2; 63.1) 6.31 (2.48; 16.3) 2.10 (0.83; 5.42) 5.56 (3.23; 10.74)

Ten-year Outcomes

Total LYs saved (thousands) 126 (54.4; 290) 114 (32.2; 317) 32.3 (11.1; 80.1) 16.2 (5.55; 40.2) 48.3 (16.6; 120) 18.4 (8.45; 31.6)
Total DALYs avertedb (thousands) 393 (172; 895) 401 (127; 1,060) 101 (34.8; 249) 50.5 (17.4; 125) 151 (52.2; 372) 57.2 (26.6; 97.9)
Total QALYs gainedb (thousands) 2,160 (1,050; 4,770) 1,890 (834; 4,530) 871 (342; 2,030) 438 (171; 1,020) 1,300 (513; 3,020) 496 (281; 716)
Healthcare Costsc ($ billions) −57.1 (−127; −27.8) −47.5 (−116; −19.5) −23.6 (−54.9; −9.33) −11.9 (−27.7; −4.67) −35.3 (−81.7; −14.0) −13.5 (−19.4; −7.61)
Net costsd ($ billions) −56.7 (−126; −27.3) −47.0 (−116; −19.1) −20.5 (−52.6; −5.86) −11.4 (−27.3; −4.23) −34.9 (−81.3; −13.5) −13.0 (−19.0; −7.19
Healthcare cost savings per $ intervention cost ($) 133 (59.6; 319) 110 (42.6; 294) 7.46 (2.69; 23.8) 27.6 (10.5; 70.4) 82.1 (31.4; 208) 31.3 (16.1; 54.5)
Net cost per LY saved ($) Cost-savinge Cost-savinge Cost-savinge Cost-savinge Cost-savinge Cost-savinge
Net cost per DALY averted ($) Cost-savinge Cost-savinge Cost-savinge Cost-savinge Cost-savinge Cost-savinge
Net cost per QALY gained ($) Cost-savinge Cost-savinge Cost-savinge Cost-savinge Cost-savinge Cost-savinge

DALYs, Disability-adjusted Life Years; Dollars, July 2014 U.S. dollars; LYs, Life-years; TEI, Total Energy Intake

a

Cost per BMI unit reduced based on two year of cost of implementation and total BMI reduction for all ages in the 2015 cohort.

b

DALYs averted and QALYs gained due to the proposed intervention are calculated as the difference in the simulated health-adjusted years of life lived in the intervention cohort over ten years compared to the baseline cohort of the United States population >1 year of age in 2015.

c

The reduction in health care costs refers to the simulated difference in ten-year healthcare costs due to the intervention for a baseline cohort of the U.S. population in 2015. Healthcare costs and health effects are estimated annually and are reported as present value in July 2014 dollars discounted at 3% annually.

d

Net costs include total implementation costs and healthcare cost savings over ten years.

e

Interventions are considered “Cost-saving,” and summary statistics are not calculated when they result in both a cost savings and a reduction in DALYs or an gain in QALYs55

f

Pass-through rates refer to the proportion of the total value of the imposed excise tax incorporated into the price paid by consumers.81